$57.26▾ 0.85%
End-of-day close · 2026-08-06
What most investors miss
Trends, drivers and alerts — the full picture.
Profit → Cash
$1.92cash per $1 profit
Strong
It turns every reported profit-dollar into real cash, and then some.
Valuation
96th pctvs its own history
Rich
Its valuation sits in the richer end of its own recent range.
Revenue growth
+11.0%year over year
Healthy
Revenue is growing at a steady pace.
Leverage
Highdebt to assets
Weak
High leverage relative to its assets.
More coming: dilution / share-count creep.
✦ The read
Royalty Pharma plc - Class A Ordinary Shares turns 192¢ of every reported profit-dollar into real cash. Revenue is growing at a steady pace. Its valuation sits in the richer end of its own recent range. High leverage relative to its assets.
Key numbers
Valuation
EPS (TTM)$1.91
TTM (trailing 12 months, through fiscal Q1 FY2026)
Profitability
Net margin33.9%
TTM (trailing 12 months, through fiscal Q1 FY2026)
Size
Revenue (TTM)$2.44B
TTM (trailing 12 months, through fiscal Q1 FY2026)
Signals and key numbers are from the fiscal Q1 FY2026 filing. Price freshness: end-of-day close on Free, 15-min delayed on Pro.